162 related articles for article (PubMed ID: 30147894)
1. Breast metastasis from EGFR-mutated lung adenocarcinoma: A case report and review of the literature.
Ota T; Hasegawa Y; Okimura A; Sakashita K; Sunami T; Yukimoto K; Sawada R; Sakamoto K; Fukuoka M
Clin Case Rep; 2018 Aug; 6(8):1510-1516. PubMed ID: 30147894
[TBL] [Abstract][Full Text] [Related]
2. Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review.
Valenza C; Porta FM; Rappa A; Guerini-Rocco E; Viale G; Barberis M; de Marinis F; Curigliano G; Catania C
Curr Oncol; 2021 Aug; 28(5):3384-3392. PubMed ID: 34590588
[TBL] [Abstract][Full Text] [Related]
3. EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report.
Dansin E; Carnot A; Servent V; Daussay D; Robin YM; Surmei-Pintilie E; Lauridant G; Descarpentries C; Révillion F; Delattre C
Case Rep Oncol; 2015; 8(1):164-8. PubMed ID: 25873885
[TBL] [Abstract][Full Text] [Related]
4. Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
Lin Q; Cai GP; Yang KY; Yang L; Chen CS; Li YP
BMC Cancer; 2016 Aug; 16():593. PubMed ID: 27488410
[TBL] [Abstract][Full Text] [Related]
5. Late breast metastasis from resected lung cancer diagnosed by epidermal growth factor receptor gene mutation.
Fukumoto K; Usami N; Okasaka T; Kawaguchi K; Okagawa T; Suzuki H; Yokoi K
Lung Cancer; 2011 Nov; 74(2):352-3. PubMed ID: 21944773
[TBL] [Abstract][Full Text] [Related]
6. Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma.
Nie Y; Gao W; Li N; Chen W; Wang H; Li C; Zhang H; Han P; Zhang Y; Lv X; Xu X; Liu H
World J Surg Oncol; 2017 Mar; 15(1):55. PubMed ID: 28253871
[TBL] [Abstract][Full Text] [Related]
7. Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis.
Fujimoto D; Ueda H; Shimizu R; Kato R; Otoshi T; Kawamura T; Tamai K; Shibata Y; Matsumoto T; Nagata K; Otsuka K; Nakagawa A; Otsuka K; Katakami N; Tomii K
Clin Exp Metastasis; 2014 Jun; 31(5):543-51. PubMed ID: 24682604
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor-mutated lung adenocarcinoma diagnosed from endometrial polyp metastasis: A case report and literature review.
Bulutay P; Bilir E; Yıldız Ş; Ata B
Turk J Obstet Gynecol; 2022 Mar; 19(1):81-86. PubMed ID: 35343222
[TBL] [Abstract][Full Text] [Related]
9. [Level of soluble programmed death-1 ligand 1 in peripheral blood of patients with advanced epidermal growth factor receptor mutated lung adenocarcinoma and its clinical implications].
Zhang LQ; Chen Y; Pan X; Xing YF; Shi MH; Chen YJ
Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(48):3870-3874. PubMed ID: 28057155
[No Abstract] [Full Text] [Related]
10. CBDCA + Pemetrexed + Bevacizumab and Its Maintenance Chemotherapy in a Case of Solitary Breast Metastasis from a Lung Adenocarcinoma Resistant to Gefitinib.
Sato K; Takeyama Y; Yoshihara M; Kato T; Hashimoto H; Fukui Y; Gonda H; Suzuki R
Case Rep Oncol; 2012 Sep; 5(3):546-53. PubMed ID: 23139670
[TBL] [Abstract][Full Text] [Related]
11. Breast metastasis from EGFR/ALK negative lung adenocarcinoma: A case report.
Cao L; Lv L
Medicine (Baltimore); 2020 Dec; 99(49):e23503. PubMed ID: 33285759
[TBL] [Abstract][Full Text] [Related]
12. Afatinib in Treatment-Naive Patients With EGFR-Mutated Lung Adenocarcinoma With Brain Metastasis: A Case Series.
Li SH; Hsieh MH; Fang YF
Medicine (Baltimore); 2015 Oct; 94(41):e1739. PubMed ID: 26469914
[TBL] [Abstract][Full Text] [Related]
13. Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report.
Liang JY; Tong F; Gu FF; Liu YY; Zeng YL; Hong XH; Zhang K; Liu L
Medicine (Baltimore); 2017 May; 96(21):e6985. PubMed ID: 28538405
[TBL] [Abstract][Full Text] [Related]
14. Two non-small cell lung cancer (NSCLC) patients with brain metastasis harboring epidermal growth factor receptor (EGFR) G719X and L861Q mutations benefited from aumolertinib: two cases report and review of the literature.
Li L
Heliyon; 2022 Sep; 8(9):e10407. PubMed ID: 36119883
[TBL] [Abstract][Full Text] [Related]
15. Bladder metastasis from epidermal growth factor receptor mutant lung cancer: A case report.
Jin CB; Yang L
World J Clin Cases; 2023 May; 11(14):3356-3361. PubMed ID: 37274049
[TBL] [Abstract][Full Text] [Related]
16. Histological transformation of lung adenocarcinoma to small cell lung cancer with mutant C797S conferring acquired resistance to osimertinib.
Ren X; Cai X; Li J; Zhang X; Yu J; Song X; Zhang H; Song X
J Int Med Res; 2020 Jun; 48(6):300060520927918. PubMed ID: 32600081
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection of advanced non-small cell lung cancer after a response to EGFR-TKI: presentation of two cases and a literature review.
Yamamoto Y; Kodama K; Maniwa T; Takeda M
J Cardiothorac Surg; 2017 Nov; 12(1):98. PubMed ID: 29169381
[TBL] [Abstract][Full Text] [Related]
18. [Response of Erlotinib in Lung Adenocarcinoma Harboring EGFR Sensitive Mutation in Cerebrospinal Fluid: Case Report].
Li X; Yang H; Xu H; Wang S; Gao H
Zhongguo Fei Ai Za Zhi; 2016 Jan; 19(1):52-6. PubMed ID: 26805738
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of T790M-positive lung adenocarcinoma after resistance to epidermal growth factor receptor-tyrosine kinase inhibitors with an emphasis on brain metastasis and survival.
Joo JW; Hong MH; Shim HS
Lung Cancer; 2018 Jul; 121():12-17. PubMed ID: 29858020
[TBL] [Abstract][Full Text] [Related]
20. CT Features of Epidermal Growth Factor Receptor-Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma.
Hasegawa M; Sakai F; Ishikawa R; Kimura F; Ishida H; Kobayashi K
J Thorac Oncol; 2016 Jun; 11(6):819-26. PubMed ID: 26917231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
